2021

Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting

Elena Argento, M Eugenia Socias, Kanna Hayashi, JinCheol Choi, Lindsay Mackay, Devon Christie, M-J Milloy, Kora DeBeck Int J Drug Policy. 2022 Feb;100:103518. doi: 10.1016/j.drugpo.2021.103518. Epub 2021 Nov 7. PMID: 34758431; PMCID: PMC8890776. CONSULTER

Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting Lire la suite »

Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial

Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, Paméla Thébault, Stéphanie Lepage, Suzanne Brissette, Julie Bruneau, Simon Dubreucq, Emmanuel Stip , Jean-François Cailhier, Didier Jutras-Aswad Neuropsychopharmacol. 46, 2101–2111 (2021). https://doi.org/10.1038/s41386-021-01098-z CONSULTER

Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial Lire la suite »